Tabula Rasa HealthCare Inc., which operates drug software maker CareKinesis among other brands, has filed this SEC statement seeking to raise $115 million in a public stock sale. The money will go to pay back investors including Eastward Fund Management and Bridge Bank NA, and to add products and buy companies.

Read on original publication

The Moorestown-based company, headed by CEO Dr. Calvin Knowlton, employs around 180 and booked sales of $50 million from Jan.-Sept. 2015, up from $35 million in the first nine months of 2014. Tabula Rasa directors and backers include Bruce Leuhrs of Rittenhouse Ventures (previously of Edison Ventures), Glen Bressner of Originate Ventures and Daniel Lubin of Radius Ventures and consultant Gordon Tunstall.